- Home
- VCIG vs MIRA Comparison
VCIG vs MIRA Comparison
Compare VCIG & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- MIRA
- Stock Information
- Founded
- VCIG 2013
- MIRA 2020
- Country
- VCIG Malaysia
- MIRA United States
- Employees
- VCIG N/A
- MIRA N/A
- Industry
- VCIG Diversified Commercial Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- MIRA Health Care
- Exchange
- VCIG Nasdaq
- MIRA Nasdaq
- Market Cap
- VCIG 15.4M
- MIRA 17.1M
- IPO Year
- VCIG 2023
- MIRA 2023
- Fundamental
- Price
- VCIG $1.62
- MIRA $1.54
- Analyst Decision
- VCIG
- MIRA Strong Buy
- Analyst Count
- VCIG 0
- MIRA 2
- Target Price
- VCIG N/A
- MIRA $14.00
- AVG Volume (30 Days)
- VCIG 705.6K
- MIRA 3.6M
- Earning Date
- VCIG 11-26-2024
- MIRA 11-12-2024
- Dividend Yield
- VCIG 30.25%
- MIRA N/A
- EPS Growth
- VCIG N/A
- MIRA N/A
- EPS
- VCIG 7.82
- MIRA N/A
- Revenue
- VCIG $23,548,256.00
- MIRA N/A
- Revenue This Year
- VCIG N/A
- MIRA N/A
- Revenue Next Year
- VCIG N/A
- MIRA N/A
- P/E Ratio
- VCIG $0.21
- MIRA N/A
- Revenue Growth
- VCIG 89.38
- MIRA N/A
- 52 Week Low
- VCIG $1.38
- MIRA $0.51
- 52 Week High
- VCIG $179.83
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- VCIG 26.44
- MIRA 50.38
- Support Level
- VCIG $1.38
- MIRA $1.42
- Resistance Level
- VCIG $1.80
- MIRA $1.75
- Average True Range (ATR)
- VCIG 0.59
- MIRA 0.29
- MACD
- VCIG -0.03
- MIRA -0.03
- Stochastic Oscillator
- VCIG 4.50
- MIRA 10.53
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.